Tisotumab vedotin in previously treated recurrent or metastatic cervical cancer:Results from the phase II innovaTV 204/GOG-3023/ENGOT-cx6 study

Authors :: Coleman, R.L.
Lorusso, D.
Gennigens, C.
González-Martín, A.
Randall, L.
Cibula, D.
Lund, B.
Woelber, L.
Pignata, S.
Forget, F.
Redondo, A.
Rangwala, R.
Vindeløv, S.D.
Chen, M.
Harris, J.R.
Nicacio, L.
Teng, M.S.L.
Smith, M.
Monk, B.J.
Vergote, I.B.
Source :: Coleman, R L, Lorusso, D, Gennigens, C, González-Martín, A, Randall, L, Cibula, D, Lund, B, Woelber, L, Pignata, S, Forget, F, Redondo, A, Rangwala, R, Vindeløv, S D, Chen, M, Harris, J R, Nicacio, L, Teng, M S L, Smith, M, Monk, B J & Vergote, I B 2020, ' Tisotumab vedotin in previously treated recurrent or metastatic cervical cancer : Results from the phase II innovaTV 204/GOG-3023/ENGOT-cx6 study ', Annals of Oncology, vol. 31, no. Suppl. 4, pp. S1162-S1163 . https://doi.org/10.1016/j.annonc.2020.08.2262
Publication Year :: 2020

Language :: English
Database :: OpenAIRE
Journal :: Coleman, R L, Lorusso, D, Gennigens, C, González-Martín, A, Randall, L, Cibula, D, Lund, B, Woelber, L, Pignata, S, Forget, F, Redondo, A, Rangwala, R, Vindeløv, S D, Chen, M, Harris, J R, Nicacio, L, Teng, M S L, Smith, M, Monk, B J & Vergote, I B 2020, ' Tisotumab vedotin in previously treated recurrent or metastatic cervical cancer : Results from the phase II innovaTV 204/GOG-3023/ENGOT-cx6 study ', Annals of Oncology, vol. 31, no. Suppl. 4, pp. S1162-S1163 . https://doi.org/10.1016/j.annonc.2020.08.2262
Accession number :: edsair.dedup.wf.001..3907c117279139277496a33567601149

Tools